PEOPLE ON THE MOVE
Dova Pharmaceuticals hires new CEO Alex Sapir
Announced this week at the J.P. Morgan conference in San Francisco, Dova Pharmaceuticals Inc. has appointed a new Chief Executive Officer, Alex Sapir.
Dova Pharmaceuticals in Virginia, US, has a focus on small molecule formulations for orphan diseases, and is currently preparing for an NDA of its Phase III candidate for thrombocytopenia (low platelet count).
Sapir has worked in the Pharmaceutical industry for 25 years, with 10 years at United Therapeutics as Exec VP of Marketing and Sales. Prior to this, Sapir was a consultant at ZS Associates and also worked at GSK in US and the EU.